|
1.
|
Zhao MF, Yan YC and Qian JQ: Relationship
between decreased renal function and renal vascular changes. Acta
Universitatis Medicinalis Secondae Shanghai. 25:505–507. 2005.(In
Chinese).
|
|
2.
|
Kang DH, Anderson S, Kim YG, et al:
Impaired angiogenesis in the aging kidney: vascular endothelial
growth factor and thrombospondin-1 in renal disease. Am J Kidney
Dis. 37:601–611. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Asahara T, Murohara T, Sullivan A, et al:
Isolation of putative progenitor endothelial cells for
angiogenesis. Science. 275:964–967. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Asahara T, Takahashi T, Masuda H, et al:
VEGF contributes to postnatal neovascularization by mobilizing bone
marrow-derived endothelial progenitor cells. EMBO J. 18:3964–3972.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Chung Y, Abou-Nassar KE, Li Y, et al:
Vascular progenitor recruitment in critically ill patients with
acute kidney injury. Clin Invest Med. 34:3042011.PubMed/NCBI
|
|
6.
|
Waksman R and Baffour R: Bone marrow and
bone marrow derived mononuclear stem cells therapy for the
chronically ischemic myocardium. Cardiovasc Radiat Med. 4:164–168.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Werner N, Kosiol S, Schiegl T, et al:
Circulating endothelial progenitor cells and cardiovascular
outcomes. N Engl J Med. 353:999–1007. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Rosenzweig A: Circulating endothelial
progenitors - cells as biomarkers. N Engl J Med. 353:1055–1057.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Aicher A, Zeiher AM and Dimmeler S:
Mobilizing endothelial progenitor cells. Hypertension. 45:321–325.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Murayama T, Tepper OM, Silver M, et al:
Determination of bone marrow-derived endothelial progenitor cell
significance in angiogenic growth factor-induced neovascularization
in vivo. Exp Hematol. 30:967–972. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Wątorek E, Paprocka M, Duś D, Kopeć W and
Klinger M: Endostatin and vascular endothelial growth factor:
potential regulators of endothelial progenitor cell number in
chronic kidney disease. Pol Arch Med Wewn. 121:296–301.
2011.PubMed/NCBI
|
|
12.
|
Futrakul N, Butthep P, Laohareungpanya N,
Chaisuriya P and Ratanabanangkoon K: A defective angiogenesis in
chronic kidney disease. Ren Fail. 30:215–217. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Rydzewska-Rosolowska A, Borawski J and
Mysliwiec M: High plasma endostatin level unaffected by
low-molecular weight heparin in hemodialysis patients - a
preliminary report. Adv Med Sci. 54:199–202. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
O’Riordan E, Mendelev N, Patschan S, et
al: Chronic NOS inhibition actuates endothelial-mesenchymal
transformation. Am J Physiol Heart Circ Physiol. 292:285–294.
2007.PubMed/NCBI
|
|
15.
|
Kohagura K, Ohya Y, Miyagi S, et al:
rHuEPO dose inversely correlated with the number of circulating
CD34+ cells in maintenance hemodialysis patients.
Nephron Clin Pract. 108:c41–c46. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Yi ZW: Henoch-Schönlein purpura nephritis.
Practical Handbook Kidney Disease in Children. People’s Medical
Publishing House; Beijing: pp. 384–390. 2005
|
|
17.
|
Katafuchi R, Kiyoshi Y, Oh Y, et al:
Glomerular score as a prognosticator in IgA nephropathy: its
usefulness and limitation. Clin Nephrol. 149:1–8. 1998.PubMed/NCBI
|
|
18.
|
Kalka C, Masuda H, Takahashi T, et al:
Transplantation of ex vivo expanded endothelial progenitor cells
for therapeutic neovascularization. Proc Natl Acad Sci USA.
97:3422–3427. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Walter DH, Rittig K, Bahlmann FH, et al:
Statin therapy accelerates reendothelialization: a novel effect
involving mobilization and incorporation of bone marrow-derived
endothelial progenitor cells. Circulation. 105:3017–3024. 2002.
View Article : Google Scholar
|
|
20.
|
Vasa M, Fichtlscherer S, Aicher A, et al:
Number and migratory activity of circulating endothelial progenitor
cells inversely correlate with risk factors for coronary artery
disease. Circ Res. 89:E1–E7. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Zhang B, Liang X, Shi W, et al: Role of
impaired peritubular capillary and hypoxia in progressive
interstitial fibrosis after 56 subtotal nephrectomy of rats.
Nephrology (Carlton). 10:351–357. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Hu F and Hu WX: Microvascular disease in
progressive renal disease. J Med Postgraduates. 11:1034–1036.
2004.(In Chinese).
|
|
23.
|
Mrowka C, Heintz B and Sieberth HG:
VCAM-1, ICAM-1, and E-selectin in IgA nephropathy and
Schönlein-Henoch syndrome: differences between tissue expression
and serum concentration. Nephron. 81:256–263. 1999.PubMed/NCBI
|
|
24.
|
Wu H, Chen H and Hu PC: Circulating
endothelial cells and endothelial progenitors as surrogate
biomarkers in vascular dysfunction. Clin Lab. 53:285–295.
2007.PubMed/NCBI
|
|
25.
|
Suzuki T, Nishida M, Futami S, et al:
Neoendothelialization after peripheral blood stem cell
transplantation in humans: a case report of a Tokaimura nuclear
accident victim. Cardiovasc Res. 58:487–492. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Shintani S, Murohara T, Ikeda H, et al:
Mobilization of endothelial progenitor cells in patients with acute
myocardial infarction. Circulation. 103:2776–2779. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Urbich C and Dimmeler S: Endothelial
progenitor cells: characterization and role in vascular biology.
Circ Res. 95:343–353. 2004. View Article : Google Scholar : PubMed/NCBI
|
